
Cadiflux L 75mg/40mg Capsule SR
Marketer
Caddix Healthcare
Salt Composition
Levosulpiride (75mg) + Pantoprazole (40mg)
Overview Cadiflux L 75mg/40mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) can be managed with Cadiflux L 75mg/40mg sustained-release capsules. This medication alleviates symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration are determined by your physician and should be followed precisely; premature discontinuation might lead to symptom recurrence and condition exacerbation. Take Cadiflux L on an empty stomach as directed. Inform your doctor about all other medications you're using, as interactions are possible. Common side effects include nausea, vomiting, diarrhea, headache, fever, abdominal pain, rash, and flatulence—most resolve spontaneously. Report any concerning side effects immediately. Dizziness is a potential side effect; avoid driving or activities requiring concentration until its impact is known. Alcohol should be avoided as it may intensify dizziness. Lifestyle adjustments, such as consuming cold milk and avoiding caffeine, spicy foods, and chocolate, can complement treatment. Prior to commencing treatment, disclose any kidney issues, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of Cadiflux L 75mg/40mg Capsule SR
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Cadiflux L 75mg/40mg Capsule SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Cadiflux L 75mg/40mg SR capsules on an empty stomach.
Common Side effects of Cadiflux L 75mg/40mg Capsule SR:
- Stomach pain
- Vomiting
- Diarrhea
- Headache
- Nausea
- Flatulence
- Fundic gland polyps
- Fever
- Skin rash
- Dizziness
How to use Cadiflux L 75mg/40mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Cadiflux L 75mg/40mg SR Capsules on an empty stomach.
How Cadiflux L 75mg/40mg Capsule SR works:
Each Cadiflux L 75mg/40mg sustained-release capsule contains levosulpiride and pantoprazole, a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Cadiflux L 75mg/40mg sustained-release capsules and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Cadiflux L 75mg/40mg SR capsules during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Prolonged-release Cadiflux L 75mg/40mg capsules are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Cadiflux L 75mg/40mg SR Capsules, which can induce drowsiness, dizziness, or involuntary movements. Patients should refrain from driving or operating machinery requiring alertness while taking this medication.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Cadiflux L 75mg/40mg sustained-release capsules. Dosage modification of Cadiflux L 75mg/40mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Cadiflux L 75mg/40mg sustained-release capsules cautiously. Dosage modification of Cadiflux L 75mg/40mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Cadiflux L 75mg/40mg Capsule SR :
Should you forget a Cadiflux L 75mg/40mg SR Capsule, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Cadiflux L 75mg/40mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
